Source: FinanzNachrichten

Soligenix: Soligenix, Inc. to Present at the virtual Fall Investor Summit on November 16th-18th

NEW YORK, NY / ACCESSWIRE / November 12, 2020 / Soligenix, Inc. (NASDAQ:SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Christopher J. Schaber's photo - Chairman & CEO of Soligenix

Chairman & CEO

Christopher J. Schaber

CEO Approval Rating


Soligenix is a late-stage biopharmaceutical company that researches and develops novel vaccines for the treatment of cancer and infectious diseases. Read more